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Acute mucosal and late radiation
responses on continuous accelerated irradiation
(CAIR) were evaluated and compared with a
conventional treatment (control arm) in 85
patients with head and neck cancer. Confluent
mucositis was significantly more severe and
m'aximum score lasting longer in CAIR than in
control arm. In the CAIR group 5 (22%) late
effects (osteo- and soft tissue necrosis) occured
early during 2-4 month of follow-up compare to
5% (1 patient) in control group. There was
significant correlation between severity of acute
reactions and these late effects in CAIR arm,
suggesting that they were consequential. The
risk of consequential effects could be predicted
by proposed time-area units system of integral
acute mucosal reaction.
INTRODUCTION
Over the last 15 years the efficacy of
many different accelerated, hyperfractionated,
or combined fractionation schedules have been
tested in pilot and randomized clinical studies
(Ang et aI., 1990; Kaanders et aI., 1992; Lamb
et aI., 1990; Nguyen et aI., 1985; Olmi et aI.,
1990; Peracchia and Salti, 1981; Saunders et
aI., 1991; Svoboda, 1984; Wang, 1988). In
general, the use of altered fractionation is
associated with more severe acute reactions
because radiation doses accumulated in time
are usually higher than in conventional
treatment schedules. Moreover, some treatment
schedules have carried a certain risk of severe
radiation effects which could be a consequence
of uncomplete healing of acute reaction rather
than typical late radiation toxicity (Nguyen et aI.,
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1985; Peracchia and Salti, 1981; Svoboda,
1984).
In 1994, at Centre of Oncology Maria
Sklodowska-Curie Institute in Gliwice, the
randomized clinical trial on Continuous
Accelerated Irradiation (CAIR) of head and neck
cancer has begun. We used single daily
fractions for 7 days a week (including Saturday
and Sunday) using constant 24 hour
interfraction intervals. This schedule is
compared with conventional 5 days per week
treatment. During the first year of follow-up
unexpectedly high rate-of early radiation
necrosis occurred in CAIR arm, what was
reported immediately (Maciejewski et aI., 1996).
The aim of this paper is to evaluate the risk of
so-called consequential late effects and their
relationships with acute mucosal reactions,
patients, tumour and treatment parameters.
MATERIAL AND METHOD
Patients
Eighty five patients were enrolled in a
randomized clinical trial between January 1,
1994 and March 31, 1996. Only patients with
histologically proven squamous cell cancer of
the oral cavity, oropharynx, supraglottic larynx
and hypopharynx in stage T2-4NO-1 MO were
eligible for the trial. Additional criteria for
inclusion were: age less or equal 70 years,
patient performance status, ZUBROD 0-1,
haemoglobin level within the normal range prior
to treatment. Patient and treatment
characteristics show the uniform distribution of
biological, clinical and dose-time parameters in
both arms of the trial. (Tab.I)
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In arm A (CAIR) a total dose of 66-68
Gy for T2 and 70-72 for T3 and T4 tumours was
given in single daily fractions, at 24 hour
intervals, 7 days per week including Saturday
and Sunday. Overall treatment time ranged from
33 to 40 days (Tab. II). Two opposed "large"
fields were used from Monday to Friday, and
during Saturday and Sunday small fields (Within
the large one) were used, the size of which was
limited to the primary tumour only.
In arm B, the fractionation schedule
differed only by overall treatment time, which
ranged from 45 to 55 days because of 5-day-a-
week fractionation (Tab II). Shrinking fields
were used in the last week of treatment. Dose
distribution was optimised by computer
treatment planning, and in agreement with the
ICRU report 29 (1988) the target absorbed
doses were specified at the midplane point.
The standard dose per fraction in the
trial was 2.0 Gy. During the first year of the
study a 22% of early necrosis was observed in
the CAIR group (Maciejewski et aI., 1996). For
this reason in the middle of 1995 we decreased
the daily dose by 10% and the standard fraction
dose of the trial became 1.8 Gy.
Quantifying acute reactions
All patients were examined
independently by the same 4 radiation
oncologists (2 of them have been qualified
specialists in both radiotherapy and laryngology)
and both tumour response and acute mucosal
reaction were assessed, at least once a week
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during the treatment. During the first 2 months of
follow-up tumour and normal tissue response
was scored every 2 weeks, and subsequently
every one month during the first year of follow-
up. Mucosal reaction score was recorded using
the modified Dische system (Dische et aI., 1989,
1994) because it places emphasis on both
morphological and functional radiation effects,
especially dysphagia and odynophagia and
subjective reaction of individual patient to the
given treatment. Mean values of scores of all
items given by independent 4 observers were
added up and the sum was taken as a measure
of the objective and subjective acute radiation
effect. Thus mucosal reaction score could be
qualified within the range of 0 - 30 points.
Supportive treatment
In order to prevent breaks during the
treatment patients with acute mucosal reaction
rapidly progressing in severity (Dische system
score ~10) received anti-inflammatory drugs
starting from local nonsteroids and antiseptic
liquids. When severity of mucositis exceeds
score 15, systemic corticosteroids and
antibiotics, and parenteral supplement of
nutrition usually were needed. No any patients
required the tube feeding during the treatment.
Supportive treatment was given to 40 patients
(91%) in CAIR and 22 patients (54%) in control
arm, and it usually started at the end of second
or third week of radiotherapy, and was
discontinued when severe reactions began to
heal and patient tolerance to treatment
improved.
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RESULTS
Acute mucositis
Figure 1 shows the time course of the
mucosal reactions according to the Dische
scale, plotting the mean scores and their 95%
CI. The earliest mucosal reactions, mainly mild
redness, were observed one week after the start
of treatment. Severity of acute mucositis
increased rapidly in both arms of the study
between the day 7th and 21st, to reach
confluent mucositis covering the entire field in
the CAIR group. In the control arm the first spots
of mucositis were observed after 3 weeks of
irradiation. The most severe mucosal reactions
(score > 15) lasting at least 2 weeks were
observed in 68% of patients in CAIR arm and
only in 28% in control arm (Fig. 1).
Fig. 1. Acute mucosal reaction course in CAIR and control
arms. Points and ranges represent the mean values of
mucosal reaction intensity with 95% confidence interval. A -
CAIR by 2.0 Gy per fraction, A(m) - modyfied CAIR by 1.8
Gy per fraction, B - conventional irradiation by 2.0 Gy per
fraction, B(m) - modyfied conventional irradiation by 1.8 Gy
per fraction.
Although the majority of patients in
CAIR suffered from severe acute mucosal
reactions, all of them except one (98%) were
able to tolerate the whole prescribed treatment
without breaks. Another one patient in CAIR arm
has not completed the treatment due to
intercurrent rectal bleeding with no relation to
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radiation. In control arm also in one patient the
treatment has not been completed because of
mucositis intolerance. .
Figure 1 shows that the whole course of
acute mucosal reaction in CAIR irradiation is
much more severe than in conventional one. In
present study time-area units (field size of area
under the curve) were calculated as a measure
of integral value of acute mucositis reaction in
function of time. This parameter strongly
correlates with the intensity of acute mucosal
reaction during the whole treatment and
postreatment course, especially with the
peak/plato phase and healing phase. The
integral acute mucosal reaction in CAIR group
was about 20% more severe than for patients in
control arm (90 time-area units versus 75
respectively, Fig. 1). The change in fraction
dose from 2.0 to 1.8 Gy per day, introduced
since 1995, gives in CAIR arm the decrease of
time-area units of about 15% (95 vs. 83,5) in
spite of average increasing the overall treatment
time by 4 days. In control arm the same change
in fraction dose has not given almost any
decrease in time-area units (77 vs. 75
respectively); the overall treatment time was
also expand in this schedule by 4 days.
"Late" effects
All patients in control arm (B) have had
a complete healing of acute-mucosal reaction. In
CAIR arm (A) healing of confluent mucositis was
prolonged in 12 patients (29%); 7 of them
needed for complete healing an extra 2-3 weeks
but remaining 5 patients developed during the
2nd to 4th month from the begining of treatment
the early mucosal necrosis. It progress rapidly in
3 patients to mandibular necrosis and in
following 2 to soft tissue necrosis. There was no
early mucosal necrosis in control arm of the
study (Tab. III). Persisted massive oedema of
the larynx (grade III) was observed during the
3rd month after the begining of treatment in 1
patient (2%) in CAIR and in anyone in the arm B
(Tab. III). Clinically, these 6 "late" sequelaes
appeared to be a consequential effects (CLE).
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..... Table II. Fractionation trial design
"'"
Fraction dose No. of fractions Total dose (Gy) Fractions Overall duration Week
(Gy) interval ofRT 1 2 3 4 5 6 7 8
ARM A . Continuous Accelerated Ir-Radiation (CAIR)
1994
2,0 33-36 66-72 24h 33-36 days 111111111111111111111111111111111111
1995
1,8 37-40 66,6-72 24h 37-40 days 1111111111111111111111111111111111111111
ARM B . Conventional Irradiation (Control)
1994
2,0 33-36 66-72 24h 45-50 days 11111 11111 11111 11111 11111 11111 11111
1995
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Table III. Late radiation toxicity
EORTC/RTOG ARM A - "CAIR"
fro dose = 2,OGy fro dose = 1,8 Gy
1994 1995
ARM B - CONTROL
fro dose = 2,0 Gy fro dose = 1,8 Gy
1994 1995
23 pts 19 pts 21 pts 19 pts
° 1 (4%) 6 (32%) 6 (28%) 9 (47%)1 11 (48%) 10 (53%) 5 (24%) 6 (32%)
2 5 (22%) 2 (10%) 7 (33%) 4 (21%)
3 1 (4%) 1 (5%)* 3 (15%) 0
4 5 (22%)* 0 0 0
* in all pts late-type reaction appeared consequently within 2-4 months after the end of RT
In our first paper concerning this trial
(Maciejewski et aI., 1996), we reported on 7
patients with consequential necrosis, but in 2 of
them the persistent and ulcerative primary
tumour was misdiagnosed as a necrosis in spite
of the negative biopsies done during the first
months of follow-up.
Five early necrosis occurred only within
the group of 23 patients (22%) irradiated in the
year 1994 when standard dose of the trial 2.0
Gy per fraction was used and this was the
reason to diminish the fraction dose to 1.8 Gy in
the both arms. A multiple biopsies were taken
Table IV. Consequential late effects
rom the necrotic area and histologic
examination revealed no evidence of tumour
cells in all 5 cases and median time of follow-up
is 25 months. Two patients were admitted to
reconstructive surgery: others 3 refused surgical
intervention, and received symptomatic
treatment only. There was no increase in the
severity of this effect during follow-up, and it was
tolerated by patients supported by antibiotics
and anti-inflammatory treatment. The
spontaneous complete healing of necrosis
occurred in 2 patients after 10 and 18 months of
follow-up (Tab. IV).
TRIAL ARM CHARACTERISTIC APPEARANCE
S
A-CAIR Massive edema of 3rd month
d. fro =1,8 Gy larynx
EORTC/RTOG - 3
A -CAIR Necrosis of right 4th month
d. fro =2,0 Gy tonsillar fossa
A-CAIR Necrosis of right 3rd month
d. fro =2,0 Gy pharyngeal wall
A-CAIR Necrosis of right 3rd month
d.fr. =2,0 Gy retromolar area
A-CAIR Necrosis of right 3rd month
d. fro =2,0 Gy retromolar area
A-CAIR Necrosis of mouth 2nd month
d. fro =2,0 Gy floor
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Table V. Clinical and treatment factors associated with consequential "late" effects
FACTOR CLE - 6 pts NO CLE - 36 pts probability
Mucosal weakness by 516 (83%) 11136 (31%) P < 0.05
tumor ulceration
Tumour fixation 516 (83%) 12136 (33%) ns
T4 416 (67%) 10136 (28%) ns
Performance status
deterioration during RT 616 16136 (44%) ns
Hemoglobin loss during
RT -1,4 ± 0,1 ·0,8 ± 0,4 p =0.05
(gfdl ± 95%CI)
Primary radiation field 130 ± 15 119 ± 6 ns
(cm2 )
Off-spinal cord radiation 90±26 76±7 ns
field (cm2 )
Weekend·boost radiation 35± 5 34±3 ns
field (cm2)
Maximal total dose
(Gy±95%CI) 76,4 ± 1,8 74,5 ± 1,0 ns
Maximal dose per
fraction 2,12 ± 0,04 1,98 ± 0,1 p =0.05
(Gy ± 95%CI)
Maximal biological dose (afl3=2Gy): 15,3 Gy (afl3=2Gy): 13,8 Gy P <0.05
accumulated per week (a/I3=5Gy): 15,1 Gy (a/I3=5Gy): 13,8 Gy p =0.05
Acute mucosal reaction
intensity 1,35±0,18 1 ± 0,1 p < 0.01
(relative units ± 95%Cf)
fig. 2
For several clinical and physical factors
the association with early mucosal necrosis was
evaluated (Tab. V). All 5 patients received a
total dose of 72 Gy, and necrosis occurred only
within the tumour bed which has been irradiated
continuously, every 24 hour, by Saturday-
Sunday boost fields treatment. In all patients
with necrosis the performance status and
haemoglobin level deteriorated significantly
during the treatment course. In 4 of 5 patients
the primary tumour was ulcerated and fixed with
deep infiltration to the pharyngeal and oral cavity
wall; as well, all these patients had poor
dentition prior to treatment.
Five of six patients in subgroup with
CLE had the highest score (>15) for acute
confluent mucositis lasting longer than 3 weeks
during treatment (Fig. 2, Tab. V). Severe and
persisted acute mucosal reactions were
significantly predictive for CLE; for patients who
developed necrosis the mean overall severity of
acute radiation mucositis measured by the time-
area units was relatively 35% higher than for
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Fig. 2. Acute mucosal reaction course in CAIR arm.
Comparison between the subgroups of patients with CLE
and with no CLE.
Analysis of individual isodose
distribution showed that mucosal necrosis
developed within the area where total and
fraction dose were planned at their maximum.
The estimated values of 76,4 Gy of total dose
and 2,12 Gy of dose per fraction estimated for
the area of necrosis were clearly higher than for
other patients in CAIR arm. Assuming that for
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fig. 3
DISCUSSION
Fig. 3. Sigmoid curve of the risk of consequential "late"
mucosal necrosis as a function of overall severity of
mucositis in CAIR arm.
1994, Skladowski et aI., 1996). In conventional
radiotherapy, it has been empirically shown that
the majority of patients can comfortably
complete the treatment without excessive acute
toxicity when the accumulated dose per week
(ADW) is 9-10 Gy. For example, Fletcher (1980)
reported that after an ADW of 10 Gy, 75% of
patients showed signs of healing during the last
week of treatment. This proportion dramatically
decreased to only 15% after moderate increase
in the ADW to 12 Gy. Accelerated and
hyperfractionated schedules are the strategies
designed to improve tumour control rate with no
or little increase of late sequelae but in aspect of
early toxicity these strategies involve a higher
ADW than conventional treatment and, in
consequence, the increased severity of acute
mucosal reactions are reported (Ang et al.,
1990; Horiot et aI., 1992; Kaanders et aI., 1992;
Lamb et aI., 1990; Nguyen et aI., 1985; Olmi et
aI., 1990; Peracchia and Salti, 1981; Saunders
et aI., 1991; Svoboda, 1984; Van der Schueren
et aI., 1990; Wang, 1988).
Early side effects of the mucous
membrane in radiation therapy of the head and
neck cancers are generally the result of
proliferating cell death in its rapidly renewing
stem-cell and transit-cell compartments. Clinical
observations and results of laboratory studies
suggest that the intensity of acute epithelial
reactions, like other H-type tissues, reflects the
balance between the rate of cell killing by
radiation and the rate of surviving stem· cells
regeneration. Once a critical level of survival
cells has been attained, a certain type of clinical
damage will develop at a rate determined only
by the cellular kinetics of the mucosa. When a
peak of mucositis intensity is reached, further
stem cell killing can not produce an increase in
intensity of acute reactions, but could be
manifest as prolonged time to heal. When acute
mucositis is extremely severe, late effects, as
radionecrosis, may develop soon after the
complete of treatment as a direct consequence
of acute injury; these are called consequential
late injuries. Consequential late injury evolves
when complete epithelial denudation occurs with
no surViving cells within the irradiated volume
such that healing, if it occurs at all, must take
place entirely by repopulation of cells from the
periphery of the radiation field (Kaanders and
Ang, 1994).
In our study the ADW of 14 Gy and later
on 12,6 Gy in CAIR was not so high as in some
studies of accelerated repopulation (Nguyen et
aI., 1985; Olmi et aI., 1990; Peracchia and Salti,
1981; Saunders et aI., 1991; Svoboda, 1984),
but was constant during the whole treatment
period (5-6 weeks). Confluent mucositis was


















mucosal necrosis a113 ratio is 2 or 5 Gy
(Kaanders and Ang, 1994) and using the Iinear-
quadratic formula (Withers et aI., 1989) the
biological accumulated dose per week within the
necrosis bed could be as high as 15,3 Gy or
15,1 Gy respectively instead of planned 14 Gy
per week.
We also note that there is an
association between the occurrence of CLE and
other factors, in particular, "late" effects tended
to occur in patients treated with larger fields and
experienced greater weight loss. But for none of
these factors was the association as strong as
between some of the acute response
characteristics and the CLE.
The estimated risk of consequential
necrosis in relation to the integral acute mucosal
reaction expressing by the values of time-area
units is shown in Figure 3. The 50% risk of early
mucosal necrosis is associated with the 155
time-area units, Le. with the course of acute
mucositis about 2-times more severe than that
accompanied with conventional irradiation 2 Gy





There is now a substantial number of
studies on radiotherapy for head and neck
cancer using altered fractionation schedules and
nearly all document an increased incidence or
severity of acute mucosal reactions. Thus, when
one considers alternative fractionation
strategies, acute mucosal reactions become
most significant dose-limiting of radiation
tolerance because mucosa is very sensitive to
dose accumulated in time (Kaanders and Ang,
Rep. Pract. Oncol. 2 (1), 1997 17
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healing was delayed compare to the control arm
where ADW was 10 Gy or 9 Gy (Fig. 1).
Although all CAIR patients, except one,
tolerated well the acute radiation toxicity, quite
unexpectedly, mucosal radionecrosis occurred
in 5 patients (22%) during 7-12 weeks after
completing the treatment. This suggests that
ADW is probably not the only parameter
determining acute mucosal reactiohs, but also
the rate at which dose is accumulated over the
whole course of the treatment may have an
important impact on overall severity and
healing-time of acute reaction.
Early development of mucosal necrosis
after the end treatment in 5 CAIR patients has
proven that it is a consequence of deep mucosal
radiation injury rather than a typical late
radiation reaction. The acute effect
characteristics which are most strongly
associated in our study with the consequential
late effects are those which involve a high
average score persisted for a long time (Fig.2).
Furthermore, in all 5 patients with consequential
necrosis the healing of mucosal reaction was
delayed and uncompleted. This suggests that
the maximum acute effect, its duration at a high
level and the delayed healing are the important
combination of factors, rather than just one of
them. Intensive, severe and persisted acute
mucosal reactions were highly predictive for
consequential effects (Tab. V). Prophylactic
parenteral nutrition, antibiotics and
corticosteroids administered to improve
tolerance and healing of acute mucositis
probably did not prevent consequential late
effects.
The value of ADW is probably the best
parameter for prediction of the intensity of
radiation mucositis. However, to predict the risk
of consequential effects for a given treatment
schedule, an additional parameter - time-area
units system - has been proposed. This way to
estimate the overall severity of acute mucositis
gives, in our opinion, the useful information on
risk of consequential mucosal necrosis for
individual patients and fractionation. Careful
measurement of integral mucosal reaction in
time-area units on the base of multifactoral
scoring system could help to predict the risk of
consequential effect even when altered,
irregular fractionation be contributed
(Skladowski et aI., 1996). The system proposed
by Dische (1989) is a spread of EORTC/RTOG
glossary and places emphasis on functional
radiation effects and morphological changes.
The determination of proper functional score,
like grade of odynophagia, is highly subjective
and needs well-experienced interviewer. But the
expanded range of score (up to 30 points) is
allowed to monitor the differences in the
18
individual intensity of confluent mucositis,
specially in accelerated intensive treatment,
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Fig. 4. Time-area units as a prognostic factor of severity and
healing of acute mucosal reaction.
As is presented in Figure 4, CAIR
irradiation with 14 Gy of ADW corresponding in
the overall severity of mucositis approaching or
exceeding 120 time-area units is correlated with
high risk (~1 0-20%) of consequential mucosal
necrosis. The problem in mucosal healing
should be expected when the overall severity of
mucositis is in amount of 80-120 time area units
(ADW - 12.6 Gy). For patients irradiated by the
same fraction doses but with weekend breaks
(control arm, ADW = 9-10 Gy) the overall
severity of mucosal reaction rarely exceeds 80
time area units, the risk of CLE is low « 1-2%)
and mucosal healing for majority of patients is
undisturbed (Fig. 4).
There is the question if enhanced
overall severity of mucositis is the result of
individual radiosensitivity or reflects the
inhomogenity of dose distribution within the
irradiated target volume (Bentzen and
Overgaard, 1996). For all patients with CLE the
maximal planned dose was located within the
area of further necrosis and usually exceeded
the planned dose by about 8%. If we assume
that alp ratio for mucosal OLE is in the range 2-
5 Gy (Kaanders and Ang, 1994) then biological
ADW in necrosis area could be, as high, as
15.1-15.3 Gy for the whole treatment period of 5
weeks. Van der Schueren et al. (1990) suggest
that oral mucosa needs very little time for
recovering and under the pressure of radiation
induced cell killing in capable of compensating
for the effect of about 1.8 Gy/day. Our previous
(Maciejewski et aI., 1991) and present results
support this suggestion, showing that even a
short 2-day radiation break during the weekend,
and a 2 week prolongation of overall treatment
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time, play an important role in physiological
response of compensating repopulation of
mucosal stem cell. Our 7-day CAIR fractionation
of 2 Gy a day during 5 weeks dangerously
"shacked" the balance between cell killing and
repopulation, although interfraction intervals
were always 24 hours. Therefore it should be
not surprised that in such extremely strained
mechanisms of recovery even a small exceed of
accumulated dose could given complete
denudation of mucosal stem cells and in the
final result - early necrosis.
Kaanders et al. (1992) suggest that
besides dose and fractionation such factors as
field size, sites treated and general patient
condition may also play an important role in
development of consequential late effects. In
the present series there was the trend to use the
larger primary and off-spinal cord radiation fields
in patients who developed CLE (Tab. V). The
mean size of "weekend-boost" fields was
identical in both groups, but the consequential
effects always developed in the bed of primary
t\Jmour, within a small area of mucosa which
was irradiated 7-days a week, and never within
a larger field which received 5 fractions per
week. Also the physiological condition of the
mucosa was weakened by tumour ulceration
and mass of deep infiltration in majority of
patients to begin with the treatment. The
performance status of all patients was good
(ZUBROD 0-1) at the begining of treatment, but
during radiation therapy deteriorated in all 6
patients with CLE (Tab. V). We observed also
during the treatment time more deep decline of
haemoglobin in these patients than in others
from CAIR arm (p=0.05). These observations
suggest that an additional factors related to the
patient condition may play the additive role in
development of consequential mucosal injuries.
CONCLUSIONS
Regular accumulation of radiation dose
in equal or above 14Gy/week produces severe
acute mucosal reaction, what in association with
poor mucosal condition could provide to defect
of mucosal healing. The continuous treatment
with 1,8Gy a day gives lower accumulation dose
in time and as yet seems to be safe and quite
tolerable.
The estimation of integral severity of
mucosal radiation reaction by proposed time-
area units system should make possible to
predict the risk of consequential late effect or
delayed mucosal healing for given fractionation
schedule in individual patient.
Rep. Pract. Oncol. 2 (1),1997
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